Description: REYON Pharmaceutical Co., Ltd. manufactures and sells finished medicines and APIs in South Korea and internationally. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis; local anesthetics; migraine drugs; miscellaneous cardiovascular system drugs; neuromuscular disorder related drugs; nootropics and neurotonics; NSAIDs; respiratory stimulants; skeletal muscle relaxants; and vasodilators. REYON Pharmaceutical Co., Ltd. was founded in 1955 and is headquartered in Seoul, South Korea.
Home Page: reyonpharm.co.kr
416 Yeongdong-daero
Seoul,
South Korea
Phone:
82 2 793 5557
Officers
| Name | Title |
|---|---|
| Ms. Soon-Ock Jung | Chairman & CEO |
| Yong-Hwan Yoo | Pres, CEO & Representative Director |
| Chang-Yeol Park | Managing Director |
| Kyu-Sang Choi | Managing Director |
| Jung-Hwan Kim | Managing Director |
| Hung-Muk Choi | Exec. Director |
Exchange: KO
Country: KR
Currency: Korean Won (₩)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.6827 |
| Price-to-Sales TTM: | 2.6824 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 477 |